-5%
Tablet, Generic Name: Repaglinide, Manufacturer: Incepta Pharmaceuticals Ltd.
- For patients not previously treated or whose HbA1c is <8%, the starting dose should be 0.5 mg before each meal.
- For patients previously treated with blood glucose-lowering drugs and whose HbA1c is >8%, the initial dose is 1 or 2 mg before each meal.
- Repaglinide should be taken immediately or up to 30 minutes before each meal.
- Dosage should be adjusted according to response at intervals of 1-2 weeks; up to 4 mg may be given as a single-dose, maximum 16 mg daily.